Scholars Central

Mini reviewPublished 2018

Superbug Infection

Authors: Reshma Rajendran

Journal of Drug Metabolism & Toxicology

Volume 9 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antibiotic resistance has led to the development of so-called “superbugs” that no longer respond to the current treatment modalities. The antibiotics available to treat these infections are dwindling with very few antibiotics in the pipeline. Infectious diseases are one of the major causes of mortality in children in developing and underdeveloped countries. Limited knowledge of targets (cell wall synthesis, replication, transcription, protein synthesis) for antibiotics and lack of novel antibiotics have led to an emergence of different level of resistance in bacterial pathogens. Multidrug resistance is the phenomenon by which the bacteria exert resistance against the two or more structurally unrelated drugs/antibiotics. In this review, the key mechanisms of resistance in bacterial superbugs have been discussed as well as that how we can overcome them.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Drug Metabolism & Toxicology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Drug Metabolism & Toxicology
  • SubjectDiabetes & Endocrinology
  • SubjectPharmaceutical Sciences
  • SubjectToxicology
  • BylineArticles whose byline prints “Reshma Rajendran”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels